Hypoxia-induced Tumor Heterogeneity and Immune Evasion

Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions

explores how hypoxic stress within the tumor microenvironment drives cancer progression, immune escape, and resistance to therapy.

This volume integrates foundational and cutting-edge insights into tumor biology, immunology, and therapeutic innovation.

The book is structured into five parts, covering tumor heterogeneity, hypoxia-driven mechanisms, immune evasion, clinical diagnostics, and future directions.

It brings together global experts to examine how hypoxia shapes tumor evolution, alters immune responses, and influences treatment outcomes.

Topics include metabolic reprogramming, angiogenesis, immune suppression, and hypoxia-targeted therapies, with emphasis on translational relevance.

This resource benefits researchers, clinicians, and advanced students by offering a comprehensive, up-to-date synthesis of a rapidly evolving field.

It supports deeper understanding of tumor complexity and equips readers with knowledge to inform experimental design, clinical strategies, and therapeutic development in oncology.